We are live on ! Find out more
MET.PRE icon

MetLife Inc 5.625% Series E Preferred Stock
MET.PRE

4 hedge funds and large institutions have $6.38M invested in MetLife Inc 5.625% Series E Preferred Stock in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding

Funds holding: 1 → 4 (+3)

0.01% more ownership

Funds ownership: 0.85% → 0.86% (+0.01%)

3% less capital invested

Capital invested by funds: $6.61M → $6.38M (-$231K)

Holders
4
Holders Change
+3
Holders Change %
+300%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CGH
Crossmark Global Holdings
Texas
+$13.3K
2
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$6.9K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CGH
1
Crossmark Global Holdings
Texas
$6.3M +$13.3K +561 +0.2%
RFA
2
Register Financial Advisors
Georgia
$69.1K +$71.1K +3,000 New
PNC Financial Services Group
3
PNC Financial Services Group
Pennsylvania
$6.7K +$6.9K +291 New
CPG
4
Cornerstone Planning Group
New Jersey
$2.5K +$2.37K +100 New

MET.PRE Hedge Fund Activity: Q4 2022 in Review

4 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) for Q4 2022, worth a combined $6.38M — down 3.5% from $6.61M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new MET.PRE positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Crossmark Global Holdings, adding an estimated $13.3K.

  • 4 institutional investors held MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) as of Q4 2022, up from 1 in Q3 2022.
  • Funds reported $6.38M of MetLife Inc 5.625% Series E Preferred Stock stock for Q4 2022, down 3.5% quarter-over-quarter.
  • 3 funds opened new MetLife Inc 5.625% Series E Preferred Stock positions in Q4 2022 and 0 closed out, a net change of +3 holders.
  • The largest MetLife Inc 5.625% Series E Preferred Stock buyer in Q4 2022 was Crossmark Global Holdings, an estimated $13.3K added.

Based on aggregated 13F filings for Q4 2022.